These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 25081276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec.
    Larochelle J, Alvarez F, Bussières JF, Chevalier I, Dallaire L, Dubois J, Faucher F, Fenyves D, Goodyer P, Grenier A, Holme E, Laframboise R, Lambert M, Lindstedt S, Maranda B, Melançon S, Merouani A, Mitchell J, Parizeault G, Pelletier L, Phan V, Rinaldo P, Scott CR, Scriver C, Mitchell GA.
    Mol Genet Metab; 2012 Sep; 107(1-2):49-54. PubMed ID: 22885033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.
    Spiekerkoetter U, Couce ML, Das AM, de Laet C, Dionisi-Vici C, Lund AM, Schiff M, Spada M, Sparve E, Szamosi J, Vara R, Rudebeck M.
    Lancet Diabetes Endocrinol; 2021 Jul; 9(7):427-435. PubMed ID: 34023005
    [Abstract] [Full Text] [Related]

  • 5. NTBC treatment in tyrosinaemia type I: long-term outcome in French patients.
    Masurel-Paulet A, Poggi-Bach J, Rolland MO, Bernard O, Guffon N, Dobbelaere D, Sarles J, de Baulny HO, Touati G.
    J Inherit Metab Dis; 2008 Feb; 31(1):81-7. PubMed ID: 18214711
    [Abstract] [Full Text] [Related]

  • 6. Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.
    Couce ML, Sánchez-Pintos P, Aldámiz-Echevarría L, Vitoria I, Navas V, Martín-Hernández E, García-Volpe C, Pintos G, Peña-Quintana L, Hernández T, Gil D, Sánchez-Valverde F, Bueno M, Roca I, López-Ruzafa E, Díaz-Fernández C.
    Medicine (Baltimore); 2019 Sep; 98(39):e17303. PubMed ID: 31574857
    [Abstract] [Full Text] [Related]

  • 7. Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation.
    Joshi SN, Venugopalan P.
    Ann Trop Paediatr; 2004 Sep; 24(3):259-65. PubMed ID: 15479577
    [Abstract] [Full Text] [Related]

  • 8. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
    Holme E, Lindstedt S.
    J Inherit Metab Dis; 1998 Aug; 21(5):507-17. PubMed ID: 9728331
    [Abstract] [Full Text] [Related]

  • 9. The Québec NTBC Study.
    Québec NTBC Study Group, Alvarez F, Atkinson S, Bouchard M, Brunel-Guitton C, Buhas D, Bussières JF, Dubois J, Fenyves D, Goodyer P, Gosselin M, Halac U, Labbé P, Laframboise R, Maranda B, Melançon S, Merouani A, Mitchell GA, Mitchell J, Parizeault G, Pelletier L, Phan V, Turcotte JF.
    Adv Exp Med Biol; 2017 Aug; 959():187-195. PubMed ID: 28755196
    [Abstract] [Full Text] [Related]

  • 10. Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.
    Yeo M, Turner C, Dalton NR, Rahman Y, Vara R.
    Ann Clin Biochem; 2020 Nov; 57(6):412-419. PubMed ID: 32936663
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.
    Bärhold F, Meyer U, Neugebauer AK, Thimm EM, Lier D, Rosenbaum-Fabian S, Och U, Fekete A, Möslinger D, Rohde C, Beblo S, Hochuli M, Bogovic N, Korpel V, Dahl SV, Mayorandan S, Fischer A, Freisinger P, Dokoupil K, Heddrich-Ellerbrok M, Jörg-Streller M, van Teeffelen-Heithoff A, Lahl J, Das AM.
    Nutrients; 2020 Dec 31; 13(1):. PubMed ID: 33396520
    [Abstract] [Full Text] [Related]

  • 13. Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC.
    Thimm E, Richter-Werkle R, Kamp G, Molke B, Herebian D, Klee D, Mayatepek E, Spiekerkoetter U.
    J Inherit Metab Dis; 2012 Mar 31; 35(2):263-8. PubMed ID: 22069142
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.
    Chinsky JM, Singh R, Ficicioglu C, van Karnebeek CDM, Grompe M, Mitchell G, Waisbren SE, Gucsavas-Calikoglu M, Wasserstein MP, Coakley K, Scott CR.
    Genet Med; 2017 Dec 31; 19(12):. PubMed ID: 28771246
    [Abstract] [Full Text] [Related]

  • 15. Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.
    Zeybek AC, Kiykim E, Soyucen E, Cansever S, Altay S, Zubarioglu T, Erkan T, Aydin A.
    Pediatr Int; 2015 Apr 31; 57(2):281-9. PubMed ID: 25223216
    [Abstract] [Full Text] [Related]

  • 16. LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.
    la Marca G, Malvagia S, Materazzi S, Della Bona ML, Boenzi S, Martinelli D, Dionisi-Vici C.
    Anal Chem; 2012 Jan 17; 84(2):1184-8. PubMed ID: 22148291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)].
    Raimann E, Cornejo V, Arias C, Cabello JF, Castro G, Fernández E, de la Parra A.
    Rev Med Chil; 2012 Feb 17; 140(2):169-75. PubMed ID: 22739945
    [Abstract] [Full Text] [Related]

  • 19. Diagnosing Hepatorenal Tyrosinaemia in Europe: Newborn Mass Screening Versus Selective Screening.
    Das AM, Mayorandan S, Janzen N.
    Adv Exp Med Biol; 2017 Feb 17; 959():125-132. PubMed ID: 28755190
    [Abstract] [Full Text] [Related]

  • 20. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I.
    Crone J, Möslinger D, Bodamer OA, Schima W, Huber WD, Holme E, Stöckler Ipsiroglu S.
    Acta Paediatr; 2003 May 17; 92(5):625-8. PubMed ID: 12839296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.